in Newswire December 9, 2019

Following FDA Warning, ‘Mislabeled’ Koi CBD Products Subject of Class Action

Fausett et al. v. Koi CBD, LLC

Filed: December 5, 2019 § 2:19-cv-10318

A class action alleges Koi CBD's products are illegal in that they're systematically mislabeled and mismarketed for purposes unapproved by the FDA.

Defendant(s)

Koi CBD, LLC

Law(s)

State(s)

California

Last Updated on December 9, 2019 — 3:12 PM

Corrado Rizzi

corrado@classaction.org

Corrado Rizzi is the Managing Editor and a writer for ClassAction.org.

About ClassAction.org

ClassAction.org is a group of online professionals (designers, developers and writers) with years of experience in the legal industry.

Learn More

Before commenting, please review our comment policy.